MediWound Ltd.
MDWD Healthcare Biotechnology
MediWound Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.0 million, down 16.1% from fiscal 2024. In the quarter to June 2026, revenue fell 45.8%, EPS grew 53.7%, free cash flow fell 49.9% and total debt rose 51.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow MDWD
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
30.03 | 36.07 | 23.63 | 29.46 | 21.58 | 11.05 | 33.90 | 41.71 | 43.16 | 53.14 |
Receivables |
2.74 | 3.57 | 7.40 | 4.56 | 3.23 | 2.71 | 9.98 | 5.14 | 6.31 | 2.73 |
Inventory |
0.84 | 1.89 | 1.68 | 1.61 | 1.38 | 1.20 | 1.96 | 2.85 | 2.69 | 4.09 |
Total current assets |
33.61 | 41.52 | 32.71 | 35.63 | 26.19 | 14.95 | 45.84 | 49.70 | 52.16 | 59.96 |
Property, Plant, Equpment (Net) |
1.28 | 1.92 | 2.02 | 2.30 | 2.63 | 2.48 | 2.37 | 9.23 | 14.13 | 18.64 |
Long-Term Investments |
0.10 | 0.06 | 0.05 | 0.01 | — | 0.19 | 0.18 | 0.44 | 0.44 | 0.44 |
Long-term receivables |
— | — | — | — | — | 0.47 | 0.18 | 0.23 | — | 0.03 |
Goodwill and Intangible Assets (Total) |
0.77 | 0.64 | 0.50 | 0.43 | 0.36 | 0.30 | 0.23 | 0.17 | 0.10 | 0.03 |
Total non-current assets |
2.15 | 2.62 | 2.56 | 4.96 | 4.88 | 4.79 | 4.18 | 16.76 | 21.33 | 26.29 |
Total Assets |
35.76 | 44.14 | 35.28 | 40.59 | 31.07 | 19.74 | 50.02 | 66.46 | 73.50 | 86.26 |
Accounts Payable |
3.32 | 3.25 | 2.72 | 4.07 | 2.99 | 4.69 | 5.66 | 5.53 | 5.28 | 7.65 |
Other current liabilities |
3.92 | 2.18 | 0.15 | 0.57 | 2.42 | 2.41 | 2.24 | 8.71 | 17.70 | 13.53 |
Total current liabilities |
5.38 | 5.43 | 4.90 | 10.37 | 8.27 | 10.72 | 12.06 | 18.13 | 26.54 | 25.71 |
Non-current Revenue (Deferred) |
1.02 | 0.99 | 1.16 | 1.14 | 1.23 | 0.12 | — | — | — | — |
Non-current Liabilities (Other) |
21.59 | 22.09 | 14.25 | 11.91 | 12.56 | 12.10 | 26.20 | 10.39 | 9.29 | 8.76 |
Total non-current liabilities |
22.61 | 29.08 | 21.41 | 15.05 | 15.53 | 13.61 | 27.05 | 16.74 | 15.80 | 16.92 |
Total liabilities |
27.99 | 34.52 | 26.30 | 25.42 | 23.80 | 24.33 | 39.10 | 34.86 | 42.34 | 42.62 |
Additional Paid In Capital |
114.98 | 138.99 | 139.64 | 140.87 | 142.19 | 143.87 | 178.88 | 206.25 | 236.00 | 272.33 |
Common Stock (Net) |
0.06 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.14 | 0.18 | 0.22 | 0.26 |
Retained Earnings |
(107.26) | (129.41) | (130.71) | (125.76) | (134.96) | (148.51) | (168.11) | (174.82) | (205.05) | (228.92) |
Shareholders Equity (Other) |
(0.01) | (0.04) | (0.02) | (0.02) | (0.04) | (0.02) | 0.00 | (0.02) | (0.01) | (0.03) |
Common Equity (Total) |
7.77 | 9.62 | 8.97 | 15.17 | 7.27 | (4.58) | 10.91 | 31.60 | 31.15 | 43.63 |
Shareholders Equity (Total) |
7.77 | 9.62 | 8.97 | 15.17 | 7.27 | (4.58) | 10.91 | 31.60 | 31.15 | 43.63 |
Shareholders Equity and Liabilities (Total) |
35.76 | 44.14 | 35.28 | 40.59 | 31.07 | 19.74 | 50.02 | 66.46 | 73.50 | 86.26 |
Shares (Common) |
3.13 | 3.87 | 3.89 | 3.89 | 3.89 | 3.90 | 7.24 | 9.23 | 10.79 | 12.84 |
Shareholders Equity (Tangible) |
7.00 | 8.99 | 8.48 | 14.74 | 6.91 | (4.88) | 10.68 | 31.43 | 31.05 | 43.60 |
Net Debt |
(30.03) | (36.07) | (23.63) | (29.46) | (21.58) | (11.05) | (33.89) | (41.71) | (43.16) | (53.14) |
Total Debt |
— | — | — | 2.58 | 2.31 | 1.99 | 1.38 | — | — | — |